clopidogrel has been researched along with dinoprostone in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Dagher, Z; Gerhardinger, C; Hoehn, T; Lorenzi, M; Sun, W | 1 |
| Lanas, A; Nardulli, G | 1 |
| Andrésson, T; Bjarnadottir, M; Bjornsson, JM; Fabre, JE; Gurney, ME; Hategen, G; Kiselyov, A; Magnusson, O; Mishra, R; Onua, E; Polozov, A; Ramírez, JL; Sigthorsson, G; Singh, J; Stefansson, K; Thorsteinsdottir, M; Yu, P; Zeller, W; Zembower, D; Zhang, J; Zhou, N | 1 |
| Charles, AL; Fabre, JE; Geny, B; Gross, S; Gurney, ME; Ludwig, S; Meilhac, O; Slimani, F; Stefansson, K; Tilly, P | 1 |
| Carlson, NG; Ecelbarger, CM; Heiney, KM; Kishore, BK; Müller, CE; Peti-Peterdi, J; Riquier-Brison, A; Zhang, Y | 1 |
1 review(s) available for clopidogrel and dinoprostone
| Article | Year |
|---|---|
[Risk of gastrointestinal bleeding with aspirin and platelet antiaggregants].
Topics: Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Clopidogrel; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Dinoprostone; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Middle Aged; Misoprostol; Peptic Ulcer Hemorrhage; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Risk Factors; Thromboxanes; Ticlopidine | 2009 |
5 other study(ies) available for clopidogrel and dinoprostone
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Aspirin at low-intermediate concentrations protects retinal vessels in experimental diabetic retinopathy through non-platelet-mediated effects.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Blood Platelets; Clopidogrel; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Dinoprostone; Humans; Neurons; Platelet Aggregation Inhibitors; Rats; Retina; Retinal Vessels; Ticlopidine | 2005 |
Antagonists of the EP3 receptor for prostaglandin E2 are novel antiplatelet agents that do not prolong bleeding.
Topics: Acrylamides; Animals; Clopidogrel; Dinoprostone; Female; Hemorrhage; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin Antagonists; Purinergic P2 Receptor Antagonists; Rats; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP3 Subtype; Receptors, Purinergic P2Y12; Sulfones; Thrombosis; Ticlopidine | 2009 |
Blocking the EP3 receptor for PGE2 with DG-041 decreases thrombosis without impairing haemostatic competence.
Topics: Acrylamides; Animals; Blood Platelets; Clopidogrel; Dinoprostone; Disease Models, Animal; Mice; Plaque, Atherosclerotic; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Prostaglandin E, EP3 Subtype; Sulfones; Thrombosis; Ticlopidine | 2014 |
Clopidogrel attenuates lithium-induced alterations in renal water and sodium channels/transporters in mice.
Topics: Aldosterone; Animals; Aquaporin 2; Aquaporins; Arginine Vasopressin; Body Water; Clopidogrel; Dinoprostone; Epithelial Sodium Channels; Kidney; Lithium; Male; Mice; Platelet Aggregation Inhibitors; Polyuria; Receptors, Purinergic P2Y12; Sodium Channels; Solute Carrier Family 12, Member 1; Ticlopidine | 2015 |